Infectious Diseases

In new data presented at IDWeek 2018, researchers assessed changes in pneumococcal carriage and antibiotic susceptibility in children aged younger than 5 years and HIV-infected adults post-PCV10...

In a new study presented at IDWeek 2018, researchers examined the effect of required patient consent prior to HIV and HCV screening.

There is currently no approved vaccine for Lassa virus, although it is common around the world and highly prevalent in Africa.

In a new research paper presented at IDWeek 2018, researchers examined the mechanisms of adverse drug reactions to antifungal medications and cross-reactivity among a drug class.

Researchers from the CDC, who presented their research at IDWeek 2018, have estimated the burden of candidemia in the United States. No current estimates exist for understanding its burden in the United...

A new study presented at IDWeek 2018 assessed whether clinical outcomes differ in obese vs non-obese patients with candidemia.

At IDWeek 2018, researchers shared results of an analysis they conducted on the CORE50 study. The adverse CV outcomes in patients with HIV were examined.

Despite increased efforts to thwart the spread of Ebola in the DRC, the World Health Organization says a “perfect storm” may contribute to another rapid spread.

Researchers have identified an epitope of limited variability that can potentially lead to the creation of a universal influenza vaccine, which would protect against all H1 strains of the virus.

In an FDA statement, Scott Gotlieb, MD, discusses the pathogen added to the list of foodborne pathogens to routinely test for, why it was added, and the FDA’s ongoing efforts to screen domestic and imported...